| URL | https://www.houstonpublicmedia.org/articles/news/h |
| Source | Houston Public Media |
| Date Published | 08/28/2024 |
| Author Name | Dominic Anthony Walsh |
| Company/Division name | Healgen Scientific |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 60 |
| Year reshoring announced: | 2024 |
| Domestically, the work will be done: | In-house |
| Country(ies) from which reshored: | China |
| City reshored to: | Houston |
| State(s) reshored to: | TX |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | covid tests |
| What domestic positive factors made reshoring more attractive? | Impact on domestic economy |